KIAWAH ISLAND, S.C. — Several treatments are available across the landscape of proliferative diabetic retinopathy, each with their own considerations, according to a speaker.
At Kiawah Eye and Retina, David Baxley, MD, a resident at Medical University of South Carolina’s Storm Eye Institute, offered an overview of available therapies.
“Panretinal photocoagulation has been the standard ever since the Diabetic Retinopathy Study showed a 60% reduction in severe vision loss. Protocol S showed us that intravitreal ranibizumab reduced the need for vitrectomy afterwards to 4% vs. 15% with PRP,” he